NICE guidelines (NG28) recommend specific injectable GLP-1 receptor agonists for type 2 diabetes management in appropriate clinical contexts
They still have a really strong presence in diabetes related therapies and keep pushing further innovation for long-term disease care, you know
Drug shortages also cause delays and inconsistent availability
Back Zunz E, La Barre, J (1929) 'Contributions a l'tude des variation physiologiques de la scrtion interne de pancras: relations entre les secretions externe et interne du pancras', Archives Internationales Physiolologie et de Biochimie , 31/1, 20-44
Activation of GLP-1 leads to lower blood sugar levels and reduced food intake, contributing to healthy weight maintenance
Statistical analyses The repeatability of findings was confirmed by performing all experiments a minimum of three times